Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

442.00INR
3:52pm IST
Price Change (% chg)

Rs0.75 (+0.17%)
Prev Close
Rs441.25
Open
Rs441.75
Day's High
Rs447.80
Day's Low
Rs438.00
Volume
794,876
Avg. Vol
1,605,576
52-wk High
Rs460.65
52-wk Low
Rs366.50

CIPL.NS

Chart for CIPL.NS

About

Cipla Limited is a pharmaceutical company. During the fiscal year ended March 31, 2012 (fiscal 2012), it introduced a number of new drugs and formulations, such as Adgain (vital nutritional supplement for hair loss); Capnea (caffeine citrate injection and oral solution) for apnoea of prematurity in infants; Caspogin (caspofungin... (more)

Overall

Beta: 0.50
Market Cap (Mil.): Rs354,289.09
Shares Outstanding (Mil.): 802.92
Dividend: 2.00
Yield (%): 0.45

Financials

  CIPL.NS Industry Sector
P/E (TTM): 25.53 35.48 35.92
EPS (TTM): 17.29 -- --
ROI: -- 18.97 18.26
ROE: -- 19.75 19.14
Search Stocks

UPDATE 1-S.African govt awards $33 mln respiratory contract to Cipla

CAPE TOWN, June 26 - South Africa has awarded Cipla Medpro a 345 million rand ($32.6 million) share in the national respiratory tender as Africa's most advanced economy seeks to cut high asthma mortality rates, the company said on Thursday.

26 Jun 2014

S.African govt awards $33 mln respiratory contract to Cipla

CAPE TOWN, June 26 - South Africa has awarded Cipla Medpro a 345 million rand ($32.6 million) share in the national respiratory tender as Africa's most advanced economy seeks to cut high asthma mortality rates, the company said on Thursday.

26 Jun 2014

UPDATE 1-Indian shares fall over 1 pct on Iraq conflict; Fed on watch

* BSE index falls 1.1 pct; NSE index down 0.96 pct * Cipla touches 8-1/2 month high on stake-sale talk * Reliance slumps post annual shareholder meeting (Adds more stocks, and updates price action) By Abhishek Vishnoi MUMBAI, June 18 - Indian shares slipped more than 1 percent on Wednesday, falling for three out of four sessions as blue-chips including oil refiners slumped on concerns about the impact of higher oil prices on inflation and the government's finances.

18 Jun 2014

MARKET EYE -India's Cipla touches 8-1/2 month high on stake-sale talk

* India's Cipla Ltd shares rose as much as 7.3 percent to 443.25 rupees, their highest since Oct. 4, on speculation that the company's founders are in talks to sell stake to a global pharmaceutical company, multiple dealers say. * A spokeswoman for the generic drugmaker termed the rumour as baseless. (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

18 Jun 2014

Cipla Q4 net profit down 3 percent on higher costs

MUMBAI - Drugmaker Cipla Ltd on Thursday reported a 3 percent drop in fourth-quarter net profit, slightly below analysts' estimates due to higher raw material and employee expenses.

29 May 2014

India's Cipla Q4 net profit down 3 pct on higher costs

MUMBAI, May 29 - Indian drugmaker Cipla Ltd on Thursday reported a 3 percent drop in fourth-quarter net profit, slightly below analysts' estimates due to higher raw material and employee expenses.

29 May 2014

UBS downgrades Cipla to 'sell'; shares fall

Reuters Market Eye - Shares of Cipla Ltd fall after UBS downgrades the stock to "sell" from "buy" and reduces its target to 370 rupees from 470 rupees citing "weak" earnings outlook despite "premium" valuations.

20 May 2014

MARKET EYE -UBS downgrades India's Cipla to 'sell'; shares fall

* Shares of India's Cipla Ltd fall as much as 1.5 percent after UBS downgrades the stock to "sell" from "buy" and reduces its target to 370 rupees from 470 rupees citing "weak" earnings outlook despite "premium" valuations. * "Our original expectation of earnings accretion through Medpro acquisition has not played out while SG&A (selling, general and administrative) ramp up has been much stronger than we anticipated," UBS says in its note. * Cipla acquired South Africa's Cipla Medpro for $488 mi

20 May 2014

INDIA PRESS-Cipla may put patent for new HIV drug in open access pool-Mint

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Abhiram Nandakumar in Bangalore)

11 Mar 2014

BSE Sensex ends down 255 points; Cipla shares plunge

MUMBAI - The BSE Sensex fell more than 1 percent on Thursday to post its biggest drop in one-and-a-half weeks as Cipla and Coal India slumped following disappointing earnings, while other blue chips tracked weaker global markets.

13 Feb 2014

Earnings vs. Estimates

Search Stocks